Suppr超能文献

人肝提取物中高分子量抑制剂介导的对动物细胞体外蛋白质和核酸合成的抑制作用。

Inhibition of protein and nucleic acid synthesis of animal cells in vitro mediated by high molecular weight inhibitors in human liver extract.

作者信息

Nilsson G

出版信息

Biochim Biophys Acta. 1976 Feb 5;418(3):376-96. doi: 10.1016/0005-2787(76)90298-7.

Abstract
  1. The addition of human liver extract to HeLa cells induces a reversible inhibition of the incorporation of [3H] thymidine into the DNA, [3H] uridine into the RNA, and 14C-labelled amino acids into the protein of HeLa cells. The inhibitory effects appear after treatment for 1 h and reach a maximum after 4-8 h. These effects do not depend on a defective precursor penetration, isotopic dilution or degradation of labelled precursor (thymidine-degrading enzymes were inactivated by the addition of unlabelled thymine), reduced activity of thymidine and uridine kinase, medium impairment, or an impairment of the cell-membrane function. 2. The nucleic acid synthesis-inhibiting activity of the extract seems to be dependent on cellular protein synthesis but independent of RNA synthesis which indicates that the inhibitors act in an indirect way. Furthermore, the inhibitors seem to lack the tissue-specific character of chalones. 3. The extract contains separate inhibitors of DNA, RNA and protein synthesis. These inhibitors were found to have different physical-chemical characteristics and to be macromolecules with a protein or conjugated protein character (mol. wt. approx. 90 000). 4. The possibility that the activity of the high molecular weight inhibitors resides in low molecular weight factors (bound to protein carriers) was tested: No true low molecular weight inhibitors could be liberated by extraction with trichloroacetic acid/organic solvents or by dialysis/enzymatic treatments. Nucleosides such as thymidine, uridine, and cytidine, however, were liberated and could be shown to interfere with the uptake of [3H] thymidine/[3H] uridine.
摘要
  1. 向海拉细胞中添加人肝提取物会诱导[3H]胸苷掺入DNA、[3H]尿苷掺入RNA以及14C标记的氨基酸掺入海拉细胞蛋白质的过程出现可逆抑制。抑制作用在处理1小时后出现,并在4 - 8小时后达到最大值。这些作用不依赖于有缺陷的前体渗透、同位素稀释或标记前体的降解(通过添加未标记的胸腺嘧啶使胸腺嘧啶降解酶失活)、胸苷和尿苷激酶活性降低、培养基损伤或细胞膜功能损伤。2. 提取物的核酸合成抑制活性似乎依赖于细胞蛋白质合成,但独立于RNA合成,这表明抑制剂以间接方式起作用。此外,抑制剂似乎缺乏抑素的组织特异性特征。3. 提取物含有DNA、RNA和蛋白质合成的单独抑制剂。这些抑制剂被发现具有不同的物理化学特性,并且是具有蛋白质或结合蛋白质特征的大分子(分子量约为90000)。4. 测试了高分子量抑制剂的活性是否存在于低分子量因子(与蛋白质载体结合)中的可能性:用三氯乙酸/有机溶剂萃取、透析/酶处理均无法释放出真正的低分子量抑制剂。然而,胸腺嘧啶核苷、尿嘧啶核苷和胞嘧啶核苷等核苷被释放出来,并被证明会干扰[3H]胸苷/[3H]尿苷的摄取。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验